Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study

References

• Aimo A, Chubuchny V, Vergaro G, et al. A simple echocardiographic score to rule out cardiac amyloidosis. Eur J Clin Invest. 2021;51:e13449.
   PubMed Web of Science ®Google Scholar
• Vergaro G, Aimo A, Barison A, et al. Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings. Eur J Prev Cardiol. 2020;27(17):1806–1815. doi: 10.1177/2047487319877708.
   PubMed Web of Science ®Google Scholar
• Yarlas A, Gertz MA, Dasgupta NR, et al. Burden of hereditary transthyretin amyloidosis on quality of life. Muscle Nerve. 2019;60(2):169–175. doi: 10.1002/mus.26515.
   PubMed Web of Science ®Google Scholar
• Emdin M, Aimo A, Rapezzi C, et al. Treatment of cardiac transthyretin amyloidosis: an update. Eur Heart J. 2019;40(45):3699–3706. doi: 10.1093/eurheartj/ehz298.
   PubMed Web of Science ®Google Scholar
• Gendre T, Planté-Bordeneuve V. Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy. Clin Auton Res. 2019;29(Suppl 1):25–31. doi: 10.1007/s10286-019-00624-w.
   PubMedGoogle Scholar
• Coelho T, Maurer MS, Suhr OB. THAOS-The transthyretin amyloidosis outcomes survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin. 2013;29(1):63–76. doi: 10.1185/03007995.2012.754348.
   PubMed Web of Science ®Google Scholar
• Maurer MS, Hanna M, Grogan M, et al. Genotype and phenotype of transthyretin cardiac amyloidosis in the United States: the transthyretin amyloid outcome survey (THAOS). J Am Coll Cardiol. 2016;68(2):161–172. doi: 10.1016/j.jacc.2016.03.596.
   PubMed Web of Science ®Google Scholar
• Stewart M, Shaffer S, Murphy B, et al. Characterizing the high disease burden of transthyretin amyloidosis for patients and caregivers. Neurol Ther. 2018;7(2):349–364. doi: 10.1007/s40120-018-0106-z.
   PubMed Web of Science ®Google Scholar
• Lane T, Fontana M, Martinez-Naharro A, et al. Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis. Circulation. 2019;140(1):16–26. doi: 10.1161/CIRCULATIONAHA.118.038169.
   PubMed Web of Science ®Google Scholar
• Aimo A, Rapezzi C, Perfetto F, et al. Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis. Eur J Clin Invest. 2021;51:e13598.
   PubMed Web of Science ®Google Scholar
• Green CP, Porter CB, Bresnahan DR, et al. Development and evaluation of the Kansas city cardiomyopathy questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35(5):1245–1255. doi: 10.1016/s0735-1097(00)00531-3.
   PubMed Web of Science ®Google Scholar
• https://www.rand36calculator.com/ n.d.
   Google Scholar
• Brazier JE, Harper R, Jones NMB, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–164. doi: 10.1136/bmj.305.6846.160.
   PubMed Web of Science ®Google Scholar
• Mckenna SP. Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science. BMC Med. 2011;9(1):86. doi: 10.1186/1741-7015-9-86.
   PubMed Web of Science ®Google Scholar
• Kharoubi M, Bézard M, Broussier A, et al. Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis. Front Cardiovasc Med. 2023;10:1124660. doi: 10.3389/fcvm.2023.1124660.
   PubMed Web of Science ®Google Scholar
• Adams D, Gonzalez-Duarte A, O’Riordan WD, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018;379(1):11–21. doi: 10.1056/NEJMoa1716153.
   PubMed Web of Science ®Google Scholar
• Miani D, Rozbowsky P, Gregori D, et al. The Kansas city cardiomyopathy questionnaire: italian translation and validation. Ital Hear J. 2003;4:620–626.
   PubMedGoogle Scholar
• Spertus JA, Jones PG. Development and validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire. Circ Cardiovasc Qual Outcomes. 2015;8(5):469–476. doi: 10.1161/CIRCOUTCOMES.115.001958.
   PubMed Web of Science ®Google Scholar
• Danielsen AK, Pommergaard HC, Burcharth J, et al. Translation of questionnaires measuring health related quality of life is not standardized: a literature based research study. PLoS One. 2015;10(5):e0127050. doi: 10.1371/journal.pone.0127050.
   PubMed Web of Science ®Google Scholar